Literature DB >> 24099018

Clinical manifestations and treatment of drug-induced hepatotoxicity.

Christin M Giordano1, Xaralambos B Zervos.   

Abstract

With an increase of prescription medication and herbal supplement use, drug-induced liver injury (DILI) has become an increasingly important entity. Because DILI is a usually readily treatable condition, it is essential for providers to reach a diagnosis in a timely fashion. Unfortunately, varied clinical presentations, difficulties in establishing causality, and lack of a gold standard diagnostic criterion may make early diagnosis difficult. This article seeks to define commonly used terminology, describe common clinical presentations of DILI, provide an overview of current diagnostic criteria, and provide management guidelines.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug-induced cholestasis; Drug-induced hepatocellular injury; Drug-induced liver injury; Management of drug-induced liver injury

Mesh:

Year:  2013        PMID: 24099018     DOI: 10.1016/j.cld.2013.07.003

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  2 in total

Review 1.  Evaluation of Adverse Drug Properties with Cryopreserved Human Hepatocytes and the Integrated Discrete Multiple Organ Co-culture (IdMOC(TM)) System.

Authors:  Albert P Li
Journal:  Toxicol Res       Date:  2015-06

2.  The Incidence and Predictive Factors in the Development of Acute Hepatitis in Patients with Leukemia.

Authors:  Muhsin Kaya; Recai Akdogan; Feyzullah Uçmak; Mehmet O Ayyildiz; Abdullah Karakus; Muhammet A Kaplan
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.